COVID-19 Vaccination in Rheumatic Disease Patients

Clinical trial NCT04839315 · TERMINATED

Trial details

NCT number: NCT04839315
Sponsor: Mayo Clinic
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Systemic Lupus Erythematosus Sjogren's Syndrome Inflammatory Myositis Psoriatic Arthritis Gout Ankylosing Spondylitis Arthritis of Multiple Sites Associated With Inflammatory Bowel Disease (Diagnosis)Osteoarthritis

Start date: 2021-02-15
Primary completion: 2022-02-09
Enrollment: 58

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.